Therapeutics and Targets: Identification, Validation, and Markers

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 71-80 of 89 total displayed.

Past content

Reviews
Endogenous Inhibitors of Nuclear Factor-B, An Opportunity for Cancer Control

Fei Chen
Cancer Res. 2004; 64: 8135-8138. [Abstract] [Full text] [PDF]  

Reviews
Aberrant and Alternative Splicing in Cancer

Julian P. Venables
Cancer Res. 2004; 64: 7647-7654. [Abstract] [Full text] [PDF]  

Reviews
Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice

Aaron D. Schimmer
Cancer Res. 2004; 64: 7183-7190. [Abstract] [Full text] [PDF]  

Minireview
Altered Hsp90 function in cancer: A unique therapeutic opportunity

Rochelle Bagatell and Luke Whitesell
Mol. Cancer Ther. 2004; 3: 1021-1030. [Abstract] [Full text] [PDF]  

Minireview
Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?

Mark A. Hull, Stanley C.W. Ko, and Gillian Hawcroft
Mol. Cancer Ther. 2004; 3: 1031-1039. [Abstract] [Full text] [PDF]  

Reviews
The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation

Jill Gilbert, Steve D. Gore, James G. Herman, and Michael A. Carducci
Clin. Cancer Res. 2004; 10: 4589-4596. [Abstract] [Full text] [PDF]  

Subject Review
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer

Carla A. Borgoño, Iacovos P. Michael, and Eleftherios P. Diamandis
Mol. Cancer Res. 2004; 2: 257-280. [Abstract] [Full text] [PDF]  

Minireview
G₂ checkpoint abrogators as anticancer drugs

Takumi Kawabe
Mol. Cancer Ther. 2004; 3: 513-519. [Abstract] [Full text] [PDF]  

Minireview
Cytochrome P450 enzymes: Novel options for cancer therapeutics

Morag C. E. McFadyen, William T. Melvin, and Graeme I. Murray
Mol. Cancer Ther. 2004; 3: 363-371. [Abstract] [Full text] [PDF]  

Subject Review
Inhibition of the p53-MDM2 Interaction: Targeting a Protein-Protein Interface

Patrick Chène
Mol. Cancer Res. 2004; 2: 20-28. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9